EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation Journal Article


Authors: Sanchez-Escamilla, M.; Flynn, J.; Devlin, S.; Maloy, M.; Fatmi, S. A.; Tomas, A. A.; Escribano-Serrat, S.; Ponce, D.; Sauter, C. S.; Giralt, S. A.; Scordo, M.; Perales, M. A.
Article Title: EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation
Abstract: The Endothelial Activation and Stress Index (EASIX) is a prognostic tool that uses common clinical laboratory values and has been shown to predict non-relapse mortality (NRM) and overall survival (OS) at the onset of acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT). We hypothesized that EASIX calculated at different time points pre- and post- HCT may predict NRM and OS, and that EASIX calculated at onset of GVHD may predict response to steroids. We evaluated the EASIX score pre- and post-HCT in 152 patients with lymphoid malignancies undergoing unmodified reduced intensity conditioning (RIC) alloHCT with uniform GVHD prophylaxis. In multivariate analysis, EASIX calculated pre-HCT was significantly associated with higher NRM (HR = 1.64, p = 0.009) and lower OS (HR = 1.33, p = 0.046). Furthermore, EASIX calculated at day 30 and at day 100 was associated with increased NRM (HR = 1.65, p < 0.001; and HR = 1.65, p < 0.001) and decreased OS (HR = 1.27, p = 0.018; and HR = 1.49, p < 0.001), independent of HCT-CI, disease and conditioning regimen. Our study shows that high EASIX scores at various time points pre- and post-HCT are significantly associated with poorer overall outcomes. EASIX provides an independent and easily accessible tool to predict outcomes that can be complementary to other measures of risk stratification for patients undergoing HCT. © 2023, The Author(s), under exclusive licence to Springer Nature Limited.
Keywords: retrospective studies; transplantation, homologous; hematopoietic stem cell transplantation; retrospective study; graft versus host reaction; transplantation conditioning; graft vs host disease; allotransplantation; humans; prognosis; human
Journal Title: Bone Marrow Transplantation
Volume: 58
Issue: 5
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2023-05-01
Start Page: 498
End Page: 505
Language: English
DOI: 10.1038/s41409-023-01922-8
PUBMED: 36721042
PROVIDER: scopus
PMCID: PMC10513445
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding authors are MSK authors: Miriam Sanchez-Escamilla and Miguel-Angel Perales -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1066 Giralt
  2. Craig Steven Sauter
    335 Sauter
  3. Doris Ponce
    257 Ponce
  4. Miguel-Angel Perales
    938 Perales
  5. Molly Anna Maloy
    269 Maloy
  6. Sean McCarthy Devlin
    613 Devlin
  7. Michael Scordo
    382 Scordo
  8. Jessica Flynn
    182 Flynn
  9. Samira Anjum Fatmi
    14 Fatmi